Athira Pharma Insider Ups Holding By 111% During Year [Yahoo! Finance]
Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association’s 35th International Symposium on ALS/MND
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates [Yahoo! Finance]
Athira Pharma Reports Third Quarter 2024 Financial Results and Pipeline and Business Updates
Athira Pharma to Present Results from Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton at the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 Meeting